Mankind Pharma declines over 4% after announcing block deal worth Rs 4935 crore

The inventory was buying and selling down by 4.40 per cent, or Rs 84.35, at Rs 1834.40 at 9:19 am on Tuesday after the pharma firm stated it could launch the block deal at Rs 1785.65 per share, or at a 7 per cent low cost from LTP. 

The Mankind Pharma block deal is value Rs 4935 crore. The deal has been launched at Rs 1785.65/share, at a 7 per cent low cost from LTP. Photograph: Mankind Pharma official web site/Representational